Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
Raimón Sanmartí, Héctor Corominas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1734-1734
Open Access | Times Cited: 15

Showing 15 citing articles:

Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study
Cristina Martinez-Molina, Ignasi Gich, Cèsar Díaz‐Torné, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Synthesis of cobalt selenide composite material: A novel platform of the electrochemical sensor for sensitive determination of Upadacitinib
Asena Ayşe Genç, Wiem Bouali, Nesrin Buğday, et al.
Electrochimica Acta (2024) Vol. 487, pp. 144164-144164
Closed Access | Times Cited: 11
JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy
Kajetan Kiełbowski, Paulina Plewa, Aleksandra Wiktoria Bratborska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8327-8327
Open Access | Times Cited: 7
Secondary loss‐of‐response associated with intolerance to Janus kinase inhibitor in a boy with ulcerative colitis
Yoshino Minoura, Koji Yokoyama, Yuko Okada, et al.
Pediatrics International (2025) Vol. 67, Iss. 1
Closed Access
Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment
Cristina Martinez-Molina, Sílvia Vidal, Cèsar Díaz‐Torné, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study
Andrew J.K. Östör, Eugen Feist, Prodromos Sidiropoulos, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Localization and Quantification of Post-Translational Modifications of Proteins Using Electron Activated Dissociation Fragmentation on a Fast-Acquisition Time-of-Flight Mass Spectrometer
Joanna Bons, Christie L. Hunter, Rita Chupalov, et al.
Journal of the American Society for Mass Spectrometry (2023) Vol. 34, Iss. 10, pp. 2199-2210
Open Access | Times Cited: 7
Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1347-1361
Open Access | Times Cited: 2
The etiology, pathogenesis, treatment, and development of transdermal drug delivery systems for rheumatoid arthritis
Mirza Muhammad Faran Ashraf Baig, Chi Hin Kwan, Hongkai Wu, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 4, pp. 592-607
Open Access | Times Cited: 1
Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease
Jurij Hanžel, Christopher Ma, Vipul Jairath
Immunotherapy (2024) Vol. 16, Iss. 6, pp. 345-357
Closed Access
Latest Treatment Perspectives for IBD-related Arthritis - a review
Michał Sęk, Olgerd Duchnevič, Iwona Galasińska, et al.
Journal of Education Health and Sport (2024) Vol. 61, pp. 55-72
Open Access
Safety and Efficacy of Upadacitinib in Crohn’s Disease: An Updated Systematic Review
Aliu Olalekan Olatunji, Muhammad Furrakh Maqbool, Muhammad Abid, et al.
Cureus (2024)
Open Access
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
Alberto Lo Gullo, Simone Parisi, Andrea Becciolini, et al.
Minerva Medica (2024) Vol. 115, Iss. 4
Closed Access
Localization and Quantification of Post-Translational Modifications of Proteins Using Electron Activated Dissociation Fragmentation on a Fast-Acquisition Time-of-Flight Mass Spectrometer
Joanna Bons, Christie L. Hunter, Rita Chupalov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
UPADACITINIB IN ACTION: EFFICACY AND SAFETY IN THE TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
Fatma Başıbüyük, İ̇̇smail Sarı
Rheumatology Quarterly (2023)
Open Access
Page 1

Scroll to top